ACADIA Pharmaceuticals, Inc. (ACAD) to Announce Second Quarter 2013 Financial Results on August 6, 2013
7/30/2013 7:19:56 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced that it will report its unaudited financial results for the second quarter ended June 30, 2013 on Tuesday, August 6, 2013, after the U.S. financial markets close.
Hey, check out all the research scientist jobs. Post your resume today!
comments powered by